SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-320305
Filing Date
2021-11-04
Accepted
2021-11-04 16:55:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d235114d424b5.htm 424B5 348635
2 GRAPHIC g235114g01a20.jpg GRAPHIC 47414
3 GRAPHIC g235114g11s30.jpg GRAPHIC 49887
  Complete submission text file 0001193125-21-320305.txt   484155
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251294 | Film No.: 211380866
SIC: 2834 Pharmaceutical Preparations